Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

7.14
BATS BZX Real-Time Price
As of 1:05pm ET
 +0.01 / +0.14%
Today’s Change
4.50
Today|||52-Week Range
11.69
+6.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$528.1M

Company Description

Inovio Pharmaceuticals, Inc. is a bio-pharmaceutical company, which develops active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies include SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Contact Information

Inovio Pharmaceuticals, Inc.
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462-1111
P:(267) 440-4200
Investor Relations:
(858) 410-3101

Employees

Shareholders

Individual stakeholders6.92%
Mutual fund holders17.19%
Other institutional12.47%

Top Executives

J. Joseph KimPresident, Chief Executive Officer & Director
Niranjan Y. SardesaiChief Operating Officer
Peter D. KiesChief Financial Officer
Jessica LeeVice President-Clinical Operations & Compliance
Mark L. BagarazziChief Medical Officer